Institute for Systems Biology, 401 Terry Avenue North Seattle, WA 98109-5263, USA.
Trends Cancer. 2021 Apr;7(4):309-322. doi: 10.1016/j.trecan.2020.12.007. Epub 2021 Feb 1.
Post-treatment progression of tumors is commonly explained by somatic Darwinian evolution (i.e., selection of cells carrying genetic mutations that create more aggressive cell traits). But cancer genome and transcriptome analyses now paint a picture far more complex, prompting us to see beyond the Darwinian scheme: non-genetic cell phenotype plasticity explained by alternative stable gene expression states ('attractors'), may also produce aggressive phenotypes that can be selected for, without mutations. Worse, treatment may even induce cell state transitions into more malignant attractors. We review recent evidence for non-genetic mechanisms of progression, explain the theoretical foundation of attractor transitions behind treatment-induced increase of aggressiveness, and provide a framework for unifying genetic and non-genetic dynamics in tumor progression.
肿瘤的治疗后进展通常可以用体细胞达尔文进化来解释(即选择携带导致更具侵袭性细胞特征的基因突变的细胞)。但是,癌症基因组和转录组分析现在描绘出的图景要复杂得多,促使我们超越达尔文主义模式:通过替代稳定的基因表达状态(“吸引子”)来解释非遗传细胞表型可塑性,也可能产生侵袭性表型,而无需突变即可被选择。更糟糕的是,治疗甚至可能诱导细胞状态向更恶性的吸引子转变。我们回顾了非遗传机制进展的最新证据,解释了治疗诱导侵袭性增加背后的吸引子转变的理论基础,并为肿瘤进展中遗传和非遗传动力学的统一提供了框架。